Viking Therapeutics
VKTX
#2792
Rank
โ‚ฌ4.54 B
Marketcap
40,76ย โ‚ฌ
Share price
1.83%
Change (1 day)
149.11%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -โ‚ฌ90.68 Million

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ82.88 Million a decrease over its 2022 earnings that were of -โ‚ฌ66.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ90.68 Million9.41%
2023 -โ‚ฌ82.88 Million24.73%
2022 -โ‚ฌ66.45 Million25.24%
2021 -โ‚ฌ53.06 Million39.23%
2020 -โ‚ฌ38.11 Million53.21%
2019 -โ‚ฌ24.88 Million16.84%
2018 -โ‚ฌ21.29 Million7.22%
2017 -โ‚ฌ19.86 Million39.68%
2016 -โ‚ฌ14.22 Million-37.05%
2015 -โ‚ฌ22.58 Million6.94%
2014 -โ‚ฌ21.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.48 Billion 400.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.63 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.54 M-119.39%๐Ÿ‡บ๐Ÿ‡ธ USA